APPLICATIONS PUBLISHED 1 DECEMBER 2004
Published: 2-Aug-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Jojoba product for reducing weight, blood lipid levels and for the prevention and treatment of cancer
Arizona Health Consulting Group 1480613*
Emulsion containing hydrophobic nanodrops with bound hemoglobin molecules in a hydrophilic phase as a blood substitute
Hemofarm Koncern 1480614*
Formenterol superfine formulation
Chiesi Farmaceutici 1480615*
Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
Chiesi Farmaceutici 1480616*
Pressurised metered dose inhalers containing solutions of beta-2 agonists
Chiesi Farmaceutici 1480617*
Sustained release drug formulations containing a carrier peptide
Societe de Conseils de Recherches et d'Applications Scientifiques 1480618*
Drug carriers comprising amphiphilic block copolymers
Biocompatibles UK 1480619*
(Ester)-lysolecithins in liposomes
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1480620*
pH-sensitive cationic lipids, and liposomes and nanocapsules containing the same
Novosom 1480621*
Immediate release pharmaceutical granule compsns and a continuous process for making them
Universiteit Gent 1480622*
Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release
Ratiopharm 1480623*
Pharmaceutical tablet
Pharmacia 1480624*
Transdermal system containing fentanyl
Hexal 1480625*
Abroxol for treating painful conditions in the mouth and pharyngeal cavity
Boehringer Ingelheim 1480626*
Methods of reducing angiogenesis
The Board of Trustees of the Leland Stanford Junior University 1480627*
Use of sodium/hydrogen exchange inhibitors for the treatment of thrombolytic and inflammatory diseases
Aventis Pharma Deutschland 1480628*
Combination therapy for the treatment of schizophrenia
Abbott Laboratories 14870629*
Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers CRP and SAA
Merck Eprova 1480630*
Methods for treating non-painful bladder disorders using alpha2-delta-subunit calcium channel modulators
Dynogen Pharmaceuticals 1480631*
A novel dosage form of L-methionine S-sulphoximine
MSO Pharma 1480632*
Nemtidicidal fatty acid and fatty acid ester related compounds
Divergence 1480633*
Treating benign prostate hyperplasis with SARMS
GTX 1480634*
Macrocyclic module compsns
Covalent Partners 1480635*
Self-emulsifying drug delivery systems for poorly soluble drugs
Novegali Pharma; Yissum Research Development Company of the Hebrew University of Jerusalem 1480636*
Pharmaceutical compsn comprising a bisphosphonate and a COX-2 inhibitor for the treatment of bone diseases
Novartis 1480637*
Porphyrins with virucidal activity
Emory University 1480638*
Combinations of am alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
Warner-Lambert 1480639*
Peroxisome proliferator activated receptor modulators
Eli Lilly 1480640*
Substituted thiazoles and oxazoles that modulate PPAR activity
Warner-Lambert 1480641*
Peroxisome proliferator activated receptor modulators
Eli Lilly 1480642*
Use of epithilones in the treatment of brain diseases associated with proliferative processes
Schering 1480643*
Novel heterocyclic compounds which are active as inhibitors of beta-lactamases
Aventis Pharma 1480644*
Inhibitors of tubulin polymerisation
Rigel Pharmaceuticals 1480645*
Anti-infective agents and/or immunomodulators used for preventative therapy following an acute cerebrovascular accident
Universitaetsklinikum Charite der Humboldt-Universitaet zu Berlin 1480646*
Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine D1 receptor agonists
Darpharma 1480647*
Anti-viral compounds
Picoral 1480648*
Stable pharmaceutical compsns
Barbeau, Donald 1480649*
Novel crystalline forms of the anti-cancer compound ZD1839
AstraZeneca 1480650*
Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery
Chiesi Farmaceutici 1480651*
Use of phospholipids in peritoneal dialysis
Britannia Pharmaceuticals 1480652*
Ribavarin syrup formulations
Schering 1480653*
Carbohydrate-based anti-wrinkle and tissue remodelling compounds
Ultraceuticals R&D 1480654*
DNA demethylase antisense and chemotherapy combination
Centre National de la Recherche Scientifique 1480655*
Hyaluronic acid mediated adenoviral transduction
Research Development Foundation 1480656*
Polymers for delivering peptides and small molecules in vivo
Intradigm 1480657*
Methods of treating vascular disease
Beth Israel Deaconess Medical Centre; University of Pittsburgh of the Commonwealth System of Higher Education 1480658*
Use of zeolithes for reducing the proportion of lactates and ammonium in human and animal organisms
Herzog, Christian; Hrashan, Jakob 1480659*
Mixed haptenised tumour cells and extracts and methods of treating or screening for cancer
Thomas Jefferson University 1480660*
Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics
Lukowski, Gerold; Juelich, Wolf-Dieter; Lindequist, Ulrike; Mundt, Sabine 1480661*
A process for producing a fraction enriched up to 100% of 3-O-accetyl-11-keto-beta-boswellic acid from an extract containing a mixture of boswellic acids
Gokaraju, Trimurtulu; Gakaraju, Rama; Gottumukkala, Vankata; Golakoti, Trimurtulu; Pratha, Sridhar 1480662*
Antiobestic and/or antidiabetic agent containing cyanidin
San-El Gen 1480663*
Compsns and methods of use of peptides in combination with biocides and/or germicides
Arizona State University 1480664*
Peptides for recognition and targetting of glial cell tumours
Auburn University 1480665*
Immunising compsn and method for inducing an immune response against the SS-secretase cleavage site of amyloid precursor protein
Ramot at Tel-Aviv University 1480666*
Combinations comprising pulmonary surfactants and a polymyxin having improved surface properties
Chiesi Farmaceutici 1480667*
Compsns and methods for promoting lipid mobilisation, glycogen mobilisation, or both, in humans
BLM Group 1480668*
Use of the insulin-like growth factor 1 splice variant MGF for the prevention of myocardial damage
University College London 1480669*
CG3842 homologous proteins involved in the regulation of energy homeostasis
DeveloGen Aktiengesellschaft fuer entwicklungsbiologische Forschung 1480670*
Recombinant RSV virus expression systems and vaccines
Aviron 1480671*
Compsns and compounds for use as a nicotine vaccine employing response selective agonist of an antigen-presenting cell receptor as a molecular adjuvant
The Board of Regents of the University of Nebraska 1480672*
A bioadhesive agent
Lyfjarthon HF Biopharmaceutical Research 1480673*
Treatment of central nervous system damage
Cambridge University Technical Services 1480674*
Immunoglobulin purification
Tranxenogen 1480675*
Combinations of an (A) an ATP-competitive inhibitor of C-ABL kinase activity with (B) two or more other anti-neoplastic agents
Novartis 1480676*
Compsn for stabilising hyaluronic acid
Ioltech 1480677*
Treatment of ophthalmic disorders using urea and urea derivatives
Vitreo-Retinal Technologies 1480678*
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
AstraZeneca 1480679*
Compsns of polymers
Biocompatibles 1480680*
Coupling low-molecular substances to a modified polysaccharide
Biotechnologie Gesellschaft Mittelhessen 1480681*
Coupling proteins to a modified polysaccharide
Biotechnologie Gesellschaft Mittelhessen 1480682*
Near-infrared fluorescent contrast agent and method for fluorescence imaging
Fuji Photo Film; Schering 1480683*
Modified phosphocalcic compound, injectable compsn containing same
Centre National de la Recherche Scientifique; Universite de Nantes; Institut National de la Sante et de la Recherche Inserm 1480687*
N-(5- 4-(4-methyl-piperazino-methyl)-benzoylamido)-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine coated stents
Novartis 1480688*
Method of treating atherosclerosis and hypercholesterolemia
Eli Lilly 1480689*
Agglomerated particles for aerosol drug delivery
Cleveland State University 1480691*
Method for production of beta-cryptoxanthin and alpha-cryptoxanthin from commercially available lutein
University of Maryland 1480932*
Process for the preparation of acitretin
Ranbaxy Laboratories 1480936*
Method of producing 2-hydroxyisobutyric acid from acetone cyanohydrin
E.I. du Pont de Nemours 1480937*
Process for the production of an alkenyl carboxylate or an alkyl carboxylate
BP Chemicals 1480938*
Reactive diluents and alkyd resin coating compsns
Ciba Specialty Chemicals 1480940*
Urea derivatives as HIV aspartyl protease inhibitors
Procyon Biopharma 1480941*
Method for the production of primary amines by hydrogenating nitriles
Clariant 1480942*
Synthesis of 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids
Teva Pharmaceutical Industries 1480943*
Substituted aryl ketones
Bayer CropScience 1480944*
Method for producing 2-chloromethylphenyl acetic acid derivatives
BASF 1480945*
A hydroxamic acid thrombospondin peptide analogue that inhibits aggrecanase activity
MP Biomedicals 1480946*
Novel pseudoceramides and cosmetic applications comprising the same
Coreana Cosmetics 1480947*
Semicarbazole derivatives and their use as antithrombotics
Merck Patent 1480948*
Preparations of prostamides
Allergan 1480949*
Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms I, VIII and IX
Teva Pharmaceutical Industries 1480950*
Synthesis of indole thiazole compounds as ligands for the AH receptor
Wisconsin Alumni Research Foundation 1480951*
Process for the synthesis of 2,2,6,6-tetramethyl-4-oxopiperidine
Uniroyal Chemical; University of Connecticut 1480952*
Process for preparing aripiprazole
Otsuka Pharmaceutical 1480953*
Vanilloid receptor modulators
Glaxo Group 1480954*
O-cyclopropyl-carboxanilides and their use as fungicides
Syngenta Participations 1480955*
Halogen-free ionic liquids
Solvent Innovation 1480956*
HPPARS activators
SmithKline Beecham 1480957*
Uracil-thioether
Bayer HealthCare 1480958*
Piperazine derivatives as anti-inflammatory agents
Glaxo Group 1480959*
Substituted 3-phenyl-5-alkanoyl-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments
Aventis Pharma Deutschland 1480960*
Glutaminyl based DPIV inhibitors
Prosidion 1480961*
5-phenylthiazole derivatives and use as P13 kinase inhibitors
Novartis 1480962*
Method for producing 3-amidinophenylalanine derivatives
Pentapharm 1480963*
Inhibitors of angiogenesis
Galderma Research & Development 1480964*
Method for purifying simvastatin
CKD Bio Corp 1480965*
Compounds and methods for treating cell proliferative diseases
Exonhit Therapeutics 1480966*
Novel fused ring compounds, and their use as cationic photoinitiators
Sun Chemical 1480967*
Thioxanthone derivatives, and their use as cationic photoinitiators
Sun Chemical 1480968*
Dithiolane derivatives for immobilising biomolecules on noble metals and semiconductors
Universitaet 1480969*
Quinoline derivatives
Novartis 1480970*
Isoquinoline derivatives
Novartis 1480971*
Compounds possessing affinity at 5HT1-type receptors and use thereof in therapy of CNS disorders
Glaxo Group 1480972*
1,4-disubstituted benzofocused cycloalkyl urea compounds useful in treating cytokine mediated diseases
Boehringer Ingelheim Pharmaceuticals 1480973*
Heterocyclylmethylpiperidines and -piperazines possessing affinity at 5HT1-type receptors
Glaxo Group 1480974*
Chemical compounds
AstraZeneca 1480975*
Thiazole derivatives as NPY receptor antagonists
F Hoffmann-La Roche 1480976*
Substituted aryl compounds for treatment of disease
Pharmacia & Upjohn 1480977*
Process for preparing 3-(2-(4-(6-fluorobenzo(D) isoxazol-3-yl)-piperidin-1yl-ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2A) pyrimidin-4-one
Ferrer Internacional 1480978*
Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
Guerbet 1480979*
Synthesis of quinazolinones
Cytokinetics; SmithKline Beecham 1480980*
1-(alkyl), 1-(heteroaryl)alkyl and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2A]pyrimidin-5(1H)-one derivatives
Sanofi-Aventis; Mitsubishi Pharma Corp 1480981*
Modified fluorinated nucleoside analogues
Pharmasset 1480982*
Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydro-pyrimido[1,2A]pyrimidin-4-one derivatives
Sanofi-Aventis; Mitsubishi PharmaCorp 1480983*
Condensed captothecins as anti-tumour agents
Chugai Seiyaku 1480984*
Salt of benzenesulphonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
Helm 1480985*
Novel benzothiazine and nezothiadiazine derivatives, method for preparing same and pharmaceutical compsns containing same
Les Laboratoires Servier 1480986*
Covalently fixed non-metallocenes, method for the production thereof and their use for polymerising olefins
Celanese Ventures 1480987*
Substituted inositols and their use
Lascaux Pharmaceuticals 1480988*
Telomerase interference
The University of Rochester 1480992*
Desaturase genes, enzymes encoded thereby and uses thereof
Abbott Laboratories 1480993*
Neurotransmission-associated proteins
Incyte Genetics 1480994*
CKS1 inhibitors
Chiron 1480995*
Amorphous fluticasone 2-furonate, pharmaceutical compsns thereof and its conversion to the crystalline unsolvated form
Glaxo Group 1480996*
Heamophilus adherence and penetration proteins
Washington University 1480997*
Intermediates and methods for making heptapeptide oxytocin analogues
Ferring 1480998*
(Substituted)acyl dipeptide inhibitors of the ICE/CED-3 family of cysteine proteases
Idun Pharmaceuticals 1480999*
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
Schering; Dendreon 1481000*
Prion inhibiting peptides and derivatives thereof
Applied Research Systems ARS Holding 1481001*
Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
University of Ottawa 1481002*
HSP70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
Hadasit Medical Research Services & Development 1481003*
Streptavidin-binding peptide
Erdmann, Volker 1481004*
DAB SP9/SP derivatives of lipopeptide antibiotics and methods of making and using the same
Micrologix Biotech 1481005*
Universal antimicrobial treatment
Zagyansky, Yuly 1481006*
Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, treatments and animal models produced therefrom
Nymox Corp 1481007*
Anti-amyloid beta antibodies and their use
F Hoffmann-La Roche; MorphoSys 1481008*
Peptides for use in antitumour immunotherapy
Institut National de la Sante et de la Recherche Medicale; Universite de Nantes 1481009*
Anti-interleukin-1 beta analogues
Eli Lilly 1481010*
Monoclonal and polyclonal antibodies recognising coagulase-negative staphylococcal proteins
Inhibitix; The Texas A&M University System 1481011*
Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerisation
Ciba Specialty Chemicals 1481012*
